[An analysis of the importance of low-molecular peptides in regulating human motor functions in diseases of the central nervous system].
The clinical data obtained on the treatment of motor disorders with intrathecal administration of low-molecular peptides, suggest that the peptides are effective in Parkinsonian disease, extrapyramidal hyperkineses and in spinal cord disturbances.
A G
AG
Naryshkin
F A
FA
Gurchun
S A
SA
Dambinova
D001480:Basal Ganglia Diseases / Q000097:blood / Q000628:therapy; D002493:Central Nervous System Diseases / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D002850:Chromatography, Gel; D006801:Humans; D007278:Injections, Spinal; D008970:Molecular Weight; D009043:Motor Activity / Q000502:physiology*; D010300:Parkinson Disease / Q000097:blood / Q000628:therapy; D010455:Peptides / Q000008:administration & dosage / Q000097:blood* / Q000302:isolation & purification; D013119:Spinal Cord Injuries / Q000097:blood / Q000628:therapy
D010455:Peptides
Analiz znacheniia nizkomolekuliarnykh peptidov v reguliatsii dvigatel'nykh funktsiĭ cheloveka pri nekotorykh zabolevaniiakh tsentral'noĭ nervnoĭ sistemy.